Key result
CF-LVAD explantation and OHT restore HMW vWF multimers within hours.
Why the study?
The precise timing of postoperative recovery of von Willebrand factor high molecular weight multimers after CF-LVAD explantation and heart transplantation was unknown.
Does CF-LVAD explantation and orthotopic heart transplantation result in the recovery of von Willebrand factor high molecular weight multimers in patients with acquired von Willebrand syndrome?
Case Report (n=1)
Does CF-LVAD explantation and orthotopic heart transplantation result in the recovery of von Willebrand factor high molecular weight multimers in patients with acquired von Willebrand syndrome?
Acquired von Willebrand syndrome associated with CF-LVADs resolves completely within hours after device explantation and heart transplantation.
Answers are grounded in this paper and cite their sources.
Immediate HMW multimer recovery within hours post-explant; supports rapid acquired vWS resolution but leaves open generalizability to peritransplant bleeding protocols.
All patients supported with continuous flow-left ventricular assist devices (CF-LVADs) develop acquired von Willebrand syndrome due to the loss of von Willebrand factor (vWF) high molecular weight (HMW) multimers and this phenomenon has been associated with clinical manifestation of bleeding diatheses. The precise timing of postoperative recovery of HMW multimers and correction of this condition after CF-LVAD explantation and heart transplantation is unknown. We sought to determine the specific timing of HMW multimer recovery by serially quantifying plasma vWF multimer ratios after CF-LVAD explant and orthotopic heart transplantation (OHT) in a patient implanted with a HeartWare ventricular assist device. Using densitometric analysis of multimer patterns, we demonstrated complete recovery of HMW multimers within the first few hours following CF-LVAD explant and OHT. These findings have critical implications in the context of perioperative bleeding diatheses in patients bridged to transplantation with a CF-LVAD.
No takes yet. Share an insight, caveat, or question.
Davis et al. (2014) conducted a case report in Acquired von Willebrand syndrome (n=1). CF-LVAD explantation and orthotopic heart transplantation was evaluated on Recovery of high molecular weight (HMW) multimers. CF-LVAD explantation and orthotopic heart transplantation resulted in complete recovery of high molecular weight von Willebrand factor multimers within the first few hours.
Synapse has enriched 10 related papers. Consider them for comparative context: